Stocksigma LogoStocksigma Logo

Shree Ganesh Bio-Tech Reports Q2 FY27 Net Loss Amid Revenue Drop

Shree Ganesh Bio-Tech (India) Ltd reported revenue from operations of ₹16.00 lakh for the quarter ended 30th Sep'26, falling 79.15% YoY from ₹76.74 lakh

Shree Ganesh Bio-Tech Reports Q2 FY27 Net Loss Amid Revenue Drop

Shree Ganesh Biotech (India) Ltd · Financial Result · 02 Nov 2026, 10:58 pm

Shree Ganesh Bio-Tech Reports Q2 FY27 Net Loss Amid Revenue Drop Shree Ganesh Bio-Tech (India) Ltd reported revenue from operations of ₹16.00 lakh for the quarter ended 30th Sep'26, falling 79.15% YoY from ₹76.74 lakh and 88.81% QoQ from ₹142.99 lakh. Total income reached ₹48.28 lakh, supported by ₹32.27 lakh in other income. Total expenses stood at ₹56.36 lakh, leading to a net loss of ₹8.08 lakh compared to a net profit of ₹1.41 lakh in Q2 FY26. For H1 FY27, revenue reached ₹158.99 lakh with a net loss of ₹65.40 lakh.

Original exchange filing (PDF)

More announcements from Shree Ganesh Biotech (India) Ltd

All Shree Ganesh Biotech (India) Ltd announcements